Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism.

Détails

ID Serval
serval:BIB_9D6FA5ECEC35
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism.
Périodique
Intensive Care Medicine
Auteur⸱e⸱s
Ganière V., Feihl F., Tagan D.
ISSN
0342-4642 (Print)
ISSN-L
0342-4642
Statut éditorial
Publié
Date de publication
2006
Volume
32
Numéro
3
Pages
452-454
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Publication Status: ppublish
Résumé
OBJECTIVE: Sildenafil has a well established pulmonary vasodilatory effect, but has seldom been used in critically ill patients. We report a case of severe recurrent pulmonary embolism in which sildenafil was used as a rescue therapy.
RESULTS: After oral administration of 50 mg of sildenafil, cardiac index increased from 2.11/min/m(2) to 3.21/min/m(2); mean pulmonary artery pressure decreased from 56 mmHg to 46 mmHg, and pulmonary vascular resistance index decreased from 700 dynes/cm(-5)/m(2) to 425 dynes/cm(-5)/m(2), without reduction of arterial systemic pressure. Clinical condition also improved during the following days under treatment of 50 mg sildenafil three times daily.
CONCLUSIONS: These observations should stimulate studies with sildenafil in the ICU setting. Sildenafil is easy to administer in every ICU and at any time. If its potential is confirmed, it may be a life-saving drug in some emergency situations caused by severe pulmonary hypertension.
Mots-clé
Female, Humans, Middle Aged, Piperazines/administration & dosage, Piperazines/pharmacology, Pulmonary Embolism/drug therapy, Pulmonary Embolism/physiopathology, Purines/administration & dosage, Purines/pharmacology, Severity of Illness Index, Sulfones/administration & dosage, Sulfones/pharmacology, Switzerland, Treatment Outcome, Vasodilator Agents/administration & dosage, Vasodilator Agents/pharmacology
Pubmed
Web of science
Création de la notice
25/01/2008 10:38
Dernière modification de la notice
20/08/2019 16:03
Données d'usage